BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Trends Analyst Outlook Journalist POV

7 hedge funds and large institutions have $1.99M invested in ProShares UltraShort NASDAQ Biotechnology in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $4K

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
$4K
Net Calls
Net Calls Change

Top Buyers

1
+$716K
2
+$135K
3
+$55.7K
4
Morgan Stanley
Morgan Stanley
New York
+$6.96K
5
Citadel Advisors
Citadel Advisors
Florida
+$3.75K

Top Sellers

1
-$303K
2
-$72K
3
-$19K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$928K
2
$590K
3
$254K
4
$203K
5
$12K
6
$3K
7
$3K
8
–
9
–